Brainstorm to present at the 2021 cell & gene meeting on the mesa

New york, oct. 4, 2021 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of cellular therapies for neurodegenerative diseases, announced today that stacy lindborg, ph.d., executive vice president and head of global clinical research, will deliver a presentation at the 2021 cell & gene meeting on the mesa, being held as a hybrid conference october 12-14, and october 19-20, 2021.
BCLI Ratings Summary
BCLI Quant Ranking